BIOMAT Database Logo BIOMAT Database Logo

[HGH response to dihydroxyphenylalanine (L-dopa) (author's transl)]. 1976

C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan

L-dopa, administered at dose levels of 250 mg., was used to assess HGH release in 36 children. In five cases of hypopituitary dwarfs no response was obtained and in the remaining 31 cases affected by short stature not of endocrine origin, the highest peak was produced 30' after the test (12.71 +/- 11.61 ng/ml; p less than 0.0005). Significant responses were also obtained at 60' (11.81 +/- 10.47 ng/ml; p less than 0.0005), 90' (7.25 +/- 7.49 ng/ml; p less than 0.0005) and 120' (4.8 +/- 4.86 ng/ml; p less than 0.005).

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D010902 Pituitary Gland A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. Hypophysis,Hypothalamus, Infundibular,Infundibular Stalk,Infundibular Stem,Infundibulum (Hypophysis),Infundibulum, Hypophyseal,Pituitary Stalk,Hypophyseal Infundibulum,Hypophyseal Stalk,Hypophysis Cerebri,Infundibulum,Cerebri, Hypophysis,Cerebrus, Hypophysis,Gland, Pituitary,Glands, Pituitary,Hypophyseal Stalks,Hypophyses,Hypophysis Cerebrus,Infundibular Hypothalamus,Infundibular Stalks,Infundibulums,Pituitary Glands,Pituitary Stalks,Stalk, Hypophyseal,Stalk, Infundibular,Stalks, Hypophyseal,Stalks, Infundibular
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004392 Dwarfism A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height. Nanism
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
[HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].
June 1976, European journal of pediatrics,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
Use of L-dopa (L-dihydroxyphenylalanine) to stimulate ovulation.
August 1973, American journal of obstetrics and gynecology,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
[Purity criteria of L-Dopa (L-dihydroxyphenylalanine)].
February 1972, Annales pharmaceutiques francaises,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
[Response of growth hormone (HGH) to L-dopa, L-arginine and their combination in normal individuals].
January 1982, Medicina clinica,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
Decreased arginine-induced HGH response during L-dopa therapy in parkinsonian patients.
December 1974, Acta endocrinologica,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
[Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
February 1981, Der Nervenarzt,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
[Stimulation of growth hormone (HGH) with L-dopa].
September 1974, L'union medicale du Canada,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
HGH radioimmunoassay. Glucagon and L-dopa stimulation tests.
January 1973, The Journal of nuclear biology and medicine,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
[Plasma growth hormone in obese patients. Comparison of response to arginine and L-dopa (author's transl)].
January 1977, Annales d'endocrinologie,
C J Del Valle Núñez, and M García Guerrero, and F García De Pesquera, and J Pérez Bryan
[The effect of L-tryptophan on L-dopa absorption (author's transl)].
January 1976, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!